Denosumab prevents acetabular bone loss around an uncemented cup: analysis of secondary outcomes in a randomized controlled trial
Background and purpose: Uncemented total hip arthroplasty (THA) is associated with periprosthetic bone loss. In a secondary outcome analysis from a randomized controlled trial, we studied whether denosumab can prevent loss of acetabular periprosthetic bone mineral density (pBMD) in patients who rec...
Main Authors: | Demostenis Kiritopoulos, Andreas Nyström, Gösta Ullmark, Jens Sörensen, Marianne Petrén-Mallmin, Jan Milbrink, Nils P Hailer, Hans Mallmin |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2022-09-01
|
Series: | Acta Orthopaedica |
Subjects: | |
Online Access: | https://actaorthop.org/actao/article/view/4537 |
Similar Items
-
Denosumab treatment in patients with different courses of osteoporosis
by: Liudmila Ya. Rozhinskaya, et al.
Published: (2017-12-01) -
Are porous tantalum cups superior to conventional reinforcement rings?: A retrospective cohort study of 207 acetabular revisions
by: Anders Brüggemann, et al.
Published: (2017-01-01) -
DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01) -
Denosumab might prevent periprosthetic bone loss after total hip and knee arthroplasties: a review
by: Jianda Xu, et al.
Published: (2021-04-01) -
Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01)